1.	Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer Phase: Phase II Type: Treatment Status: Completed Age: 19 and over Sponsor: Other Protocol IDs: EORTC-13961, NCT00002916
2.	Phase I Study of HPV16 E7 Lipopeptide Vaccine for Recurrent or Refractory Cervical Cancer (Summary Last Modified 02/98) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-95-C-0153D, NCI-T95-0041N, T95-0041
3.	Phase II Pilot Study of Human Papilloma Virus 16 (HPV16) E6 and E7 Peptide Vaccines in Patients With Advanced or Recurrent Carcinoma of the Cervix or Other Tumors Carrying HPV16 Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: NCI-95-C-0154, NCI-T94-0134N, T94-0134, NCT00019110
4.	Phase I Study of Immunization With Alternating Lipidated Human Papillomavirus 16 E7 (HPV-16 E7) Peptide Vaccine and Dendritic Cell-HPV-16 E7 Peptide Vaccine in Patients With Recurrent or Persistent Cervical Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: SEMC-980016, NCI-T98-0072, NCT00003977, T98-0072